The Lawyer’s new China Elite report contains the most detailed research available on the PRC legal market and contains unparalleled insight into the country's leading law firms. They vary in size, practice focus and geographic coverage, but they all share one common quality – ambition... Read more
This year, The Lawyer’s annual ranking of the largest UK law firms by turnover is available as an interactive, digital benchmarking tool. For the first time this will allow you to manipulate each data set against the metrics of your choice.
Olswang has lured senior patent attorney Robert Stephen away from pharmaceuticals company GlaxoSmithKline to grow its patent prosecution practice.
Olswang head of life sciences Michael Burdon said the move would benefit existing clients, such as Wellcome Trust and Cancer Research, and help the firm get instructions in new areas.
"The other angle is the venture capital and investor community," said Burdon. "They have to do due diligence in life sciences and often the patent portfolio is a key asset to a company."
The firm has also hired patent attorney Kevin Cordina, a specialist in software and electronics, and contentious IP solicitor Sarah Abbott from Eversheds. The moves will take the number of lawyers in Olswang's IP department up to 29.
Burdon said he expected the practice to grow by a third over the next 12 months.